
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28.1% of its shares and a majority of its voting shares. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Novo Nordisk (Finland), Finland, covering academic research published from 2001 to 2025. Read More.
Open Access Percentage
83%
Total
Publications
229
Total Open
Publications
190
Total
Citations
15K
Open Access
Percentage
83%
Total
Publications
229
Total Open
Publications
190
Total
Citations
15K
Breakdown
Publisher Open
17%
Both
42%
Other Platform Open
24%
Closed
17%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 36%
48
Hybrid 40%
54
No Guarantees 24%
32
Other Platform Open
Domain 63%
94
Institution 61%
91
Preprint 26%
39
Other Internet 16%
24
Public 1%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 95 |
doaj.org OAI-PMH Repository | Institution | 30 |
DOI | Other Internet | 21 |
bioRxiv | Preprint | 21 |
University of Bristol | Institution | 19 |
Unknown Repository | Other Internet | 16 |
University of Cambridge | Institution | 16 |
Imperial College London | Institution | 14 |
medRxiv | Preprint | 11 |
University of Edinburgh | Institution | 6 |